套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-122605 Act: 34 Size: 667 KB 网页链接
$Lyra Therapeutics(LYRA)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-122508 Act: 34 Size: 590 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-102914 Act: 34 Size: 143 KB 网页链接
$Lyra Therapeutics(LYRA)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-102928 Act: 34 Size: 842 KB 网页链接
$Lyra Therapeutics(LYRA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000816 Act: 33 Size: 2 KB 网页链接
$Lyra Therapeutics(LYRA)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-074566 Act: 33 Size: 1 MB 网页链接
$Lyra Therapeutics(LYRA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-074572 Act: 33 Size: 92 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-035047 Act: 34 Size: 14 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-034701 Act: 34 Size: 292 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-034350 Size: 5 KB 网页链接